Japan-India BioSciences

Japan-India BioSciences (JIBS) is a biotechnology company focused on bridging the drug discovery ecosystems of Japan and India to accelerate the development of novel therapeutics. The company leverages Japanese expertise in high-throughput screening and medicinal chemistry alongside India's robust clinical research and manufacturing capabilities. JIBS primarily focuses on early-stage drug discovery targeting G protein-coupled receptors and ion channels for indications such as chronic pain and metabolic diseases. By utilizing a collaborative cross-border model, the company aims to reduce the cost and time associated with bringing new molecular entities to the clinical stage.